Wealthcare Advisory Partners’s Compugen CGEN Stock Holding History

Wealthcare Advisory Partners’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30	Closed	–	–	764
2021 Q1	$0	Buy	+30	New	+$333	﹤0.01%	2064

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthcare Advisory Partners's CGEN Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Compugen (CGEN) in Q2 2021, closing a stake of 30 shares.

Wealthcare Advisory Partners first reported a position in CGEN in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 108 funds tracked by Wall St. Rank hold CGEN as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Compugen position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 30 Compugen shares in Q2 2021.
Wealthcare Advisory Partners first reported a position in Compugen in Q1 2021 and held it in 1 quarter.
Wealthcare Advisory Partners's Compugen position peaked at $0 in Q1 2021.
108 funds tracked by Wall St. Rank held Compugen as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.